Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial.

Riva, Thomas; Pedersen, Tina Heidi; Seiler, Stefan Jürg; Kasper, Nina Elisabeth; Theiler, Lorenz; Greif, Robert; Kleine-Brüggeney, Maren (2018). Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial. British journal of anaesthesia, 120(3), pp. 592-599. Elsevier 10.1016/j.bja.2017.12.017

[img] Text
PIIS0007091217542063.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (515kB) | Request a copy

BACKGROUND Transnasal humidified rapid insufflation ventilatory exchange (THRIVE) comprises the administration of heated, humidified, and blended air/oxygen mixtures via nasal cannula at rates of ≥2 litres kg min. The aim of this randomized controlled study was to evaluate the length of the safe apnoea time using THRIVE with two different oxygen concentrations (100% vs 30% oxygen) compared with standard low-flow 100% oxygen administration. METHODS Sixty patients, aged 1-6 yr, weighing 10-20 kg, undergoing general anaesthesia for elective surgery, were randomly allocated to receive one of the following oxygen administration methods during apnoea: 1) low-flow 100% oxygen at 0.2 litres kg min; 2) THRIVE 100% oxygen at 2 litres kg min; and 3) THRIVE 30% oxygen at 2 litres kg min. Primary outcome was time to desaturation to 95%. Termination criteria included SpOdecreased to 95%, transcutaneous COincreased to 65 mmHg, or apnoea time of 10 min. RESULTS The median (interquartile range) [range] apnoea time was 6.9 (5.7-7.8) [2.8-10.0] min for low-flow 100% oxygen, 7.6 (6.2-9.1) [5.2-10.0] min for THRIVE 100% oxygen, and 3.0 (2.4-3.7) [0.2-5.3] min for THRIVE 30% oxygen. No significant difference was detected between apnoea times with low-flow and THRIVE 100% oxygen administration (P=0.15). THRIVE with 30% oxygen demonstrated significantly shorter apnoea times (P<0.001) than both 100% oxygen modalities. The overall rate of transcutaneous COincrease was 0.57 (0.49-0.63) [0.29-8.92] kPa minwithout differences between the 3 groups (P=0.25). CONCLUSIONS High-flow 100% oxygen (2 litres kg min) administered via nasal cannulas did not extend the safe apnoea time for children weighing 10-20 kg compared with low-flow nasal cannula oxygen (0.2 litres kg min). No ventilatory effect was observed with THRIVE at 2.0 litres kg min. CLINICAL TRIAL REGISTRATION NCT02979067.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

Riva, Thomas; Pedersen, Tina Heidi; Seiler, Stefan Jürg; Kasper, Nina Elisabeth; Theiler, Lorenz; Greif, Robert and Kleine-Brüggeney, Maren

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0007-0912

Publisher:

Elsevier

Language:

English

Submitter:

Jeannie Wurz

Date Deposited:

22 Mar 2018 08:38

Last Modified:

14 Dec 2018 12:21

Publisher DOI:

10.1016/j.bja.2017.12.017

PubMed ID:

29452816

Uncontrolled Keywords:

THRIVE apnoeic oxygenation high-flow nasal cannula oxygen paediatric anaesthesia safe apnoea time

BORIS DOI:

10.7892/boris.112644

URI:

https://boris.unibe.ch/id/eprint/112644

Actions (login required)

Edit item Edit item
Provide Feedback